Portola Pharmaceuticals Inc
(737010108)
Fondsberichterstattung Bestände von Portola Pharmaceuticals Inc gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Cadian Capital Management LP | 4,091,687 | $111,007k | Jun 30, 2019 | Aug 13, 2019 | |
| Jackson Square Partners LLC | 2,546,332 | $69,081k | Jun 30, 2019 | Aug 14, 2019 | |
| Rock Springs Capital Management LP | 1,008,000 | $27,347k | Jun 30, 2019 | Aug 14, 2019 | |
| Sectoral Asset Management Inc | 721,556 | $19,576k | Jun 30, 2019 | Aug 14, 2019 | |
| Tamarack Advisers LP | 555,000 | $14,419k | Jun 30, 2019 | Aug 12, 2019 | |
| Emerald Mutual Fund Advisers Trust | 475,934 | $12,912k | Jun 30, 2019 | Jul 31, 2019 | |
| Tocqueville Asset Management LP | 468,114 | $12,700k | Jun 30, 2019 | Jul 31, 2019 | |
| ELK Creek Partners LLC | 417,589 | $11,329k | Jun 30, 2019 | Aug 9, 2019 | |
| Fernwood Investment Management LLC | 381,911 | $10,361k | Jun 30, 2019 | Aug 1, 2019 | |
| Tekla Capital Management LLC | 115,448 | $3,132k | Jun 30, 2019 | Aug 14, 2019 | |
| Atika Capital Management LLC | 36,451 | $989k | Jun 30, 2019 | Aug 12, 2019 | |
| Prelude Capital Management LLC | 34,328 | $931k | Jun 30, 2019 | Aug 14, 2019 | |
| Campbell & Company Investment Adviser LLC | 32,994 | $895k | Jun 30, 2019 | Jul 10, 2019 | |
| Family Management Corporation | 19,500 | $529k | Jun 30, 2019 | Aug 14, 2019 | |
| QS Investors LLC | 7,400 | $201k | Jun 30, 2019 | Aug 14, 2019 |